News Releases

March, 2021

March 17, 2021 2021-03-17 Health Canada approves new indication for lung cancer treatment option ALUNBRIG®

February, 2021

February 24, 2021 2021-02-24 Takeda Canada Celebrates Resilient Rare Stars on Rare Disease Day

February 8, 2021 2021-02-08 Rute Fernandes Appointed General Manager of Takeda Canada

January, 2021

January 28, 2021 2021-01-28 Takeda Applies to Cease being a Reporting Issuer in Canada

January 19, 2021 2021-01-19 Ready-to use self-injectable formulation of ENTYVIO® (vedolizumab) now available for Canadians for the maintenance treatment of moderately to severely active Crohn’s disease and ulcerative colitis

November, 2020

November 5, 2020 2020-11-05 Eligible patients living with rare debilitating genetic disorder are one step closer to having access to first-of-its-kind treatment option

July, 2020

July 7, 2020 2020-07-07 Takeda Canada Announces New OnePath® Patient Support Program

July 2, 2020 2020-07-02 Amalgamation of Takeda Canada Inc. and Shire Pharma Canada ULC Solidifies Company’s Leadership Position in Canadian Biopharmaceutical Industry